China's Sino Biopharma acquires LaNova Medicines for $951 M

China's Sino Biopharm has announced the completion of a binding Sale and Purchase Agreement to acquire LaNova Medicines....

July 18, 2025 | Friday | News
Korea's CorestemChemon expands global CRO reach with ATG Lifetech

CorestemChemon, a leading GLP-certified preclinical CRO based in South Korea, has entered into a strategic partners...

July 21, 2025 | Monday | News
Hyphens Pharma introduces novel acne treatment Winlevi in Singapore and Malaysia

Hyphens Pharma, a subsidiary of Hyphens Pharma International Limited, Singapore’s leading specialty pharmaceutical...

July 17, 2025 | Thursday | News
Japan's Astellas announces partnership with Korea Institute of Startup and Entrepreneurship Development

Japan-based Astellas Pharma Inc. has agreed on a Memorandum of Understanding (MoU) with the Korea Institute of Star...

July 17, 2025 | Thursday | News
Thermo Fisher to acquire Sanofi’s steriles manufacturing site in US to produce critical medicines

Thermo Fisher Scientific Inc. has announced an expansion of their strategic partnership with Sanofi to enable additional...

July 17, 2025 | Thursday | News
Korea-Israel partnership to commercialise injectable treatment for focal fat reduction

365mc, South Korea's leading medical institution specialising in fat reduction treatments, and Israel-based Ra...

July 16, 2025 | Wednesday | News
Biocon Biologics expands diabetes portfolio with US FDA approval of Kirsty

Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of India-based Biocon Ltd. has ...

July 16, 2025 | Wednesday | News
WHO includes ArkBio's Ziresovir into paediatric RSV drug priority list

In the newly released "Paediatric drug optimisation for respiratory syncytial virus (PADO-RSV) meeting report" by Global...

July 16, 2025 | Wednesday | News
Japan's JCR Pharma and Acumen announce collaboration to develop therapy for Alzheimer’s Disease

Japan-based JCR Pharmaceuticals Co., a global specialty biopharmaceutical company dedicated to developing therapies...

July 15, 2025 | Tuesday | News
Novo Nordisk makes Wegovy available in Singapore for weight management

A significant advancement in weight management has arrived for Singaporeans. Novo Nordisk, a global healthcare company f...

July 15, 2025 | Tuesday | News
Samsung Bioepis proposes to bridge policy gaps for timely access of biosimilar medicines in Europe

South Korea-based biopharmaceutical company Samsung Bioepis has published a whitepaper titled ‘Solving the Biosimi...

July 14, 2025 | Monday | News
DKSH and Bayer launch strategic partnership across multiple markets in Southeast Asia

DKSH Business Unit Healthcare, a Strategic Healthcare Solutions Partner and leading provider of Market Expansion Service...

July 10, 2025 | Thursday | News
Japan's JCR Pharma licenses gene therapy platform to AstraZeneca Rare Disease unit for $825 M

Japan's JCR Pharmaceuticals Co. has entered into a license agreement with Alexion, AstraZeneca Rare Disease, for JCR&rsq...

July 10, 2025 | Thursday | News
China's CStone inks deal worth $192.5 M with Istituto Gentili to commercialise cancer drug in Europe

China-based CStone Pharmaceuticals has announced an exclusive partnership with Istituto Gentili, a leading European biop...

July 10, 2025 | Thursday | News
Health2Sync and Novo Nordisk enhance insulin administration via digital diabetes care in Korea

Health2Sync, Asia's leading digital chronic disease management platform, has announced the successful integration of Sma...

July 9, 2025 | Wednesday | News
Korea's Celltrion announces US launch of denosumab biosimilars for osteoporosis treatment

Celltrion has announced that STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo), biosimila...

July 8, 2025 | Tuesday | News
Chugai and Gero ink $250 M deal to develop new therapies for age-related diseases

Japan's Chugai Pharmaceutical and Gero, a Singapore-based biotechnology company, have entered into a joint research...

July 9, 2025 | Wednesday | News
BioVersys inks deal worth CHF 479 M with Japan's Shionogi to treat infectious diseases

BioVersys AG, a multi-asset, clinical stage biopharmaceutical company based in Switzerland, focusing on research an...

July 4, 2025 | Friday | News